TY - JOUR
T1 - Survival in Pediatric Patients With Ventricular Assist Devices
T2 - A Special Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report
AU - Ashfaq, Awais
AU - Lorts, Angela
AU - Rosenthal, David
AU - Adachi, Iki
AU - Rossano, Joseph
AU - Davies, Ryan
AU - Simpson, Kathleen E.
AU - Maeda, Katsuhide
AU - Wisotzkey, Bethany
AU - Koehl, Devin
AU - Cantor, Ryan S.
AU - Jacobs, Jeffrey P.
AU - Peng, David
AU - Kirklin, James K.
AU - Morales, David L.S.
N1 - Publisher Copyright:
© 2023 The Society of Thoracic Surgeons
PY - 2023/11
Y1 - 2023/11
N2 - Background: The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) provides detailed understanding on pediatric patients supported with ventricular assist devices (VADs). We sought to identify important variables affecting mortality in pediatric VADs. Methods: Patients aged <19 years, from 2012 to 2021, were included. Survival analyses were performed using Kaplan-Meier. Parametric hazard modeling was used to identify risk factors for death. Results: Of the 1109 patients, the most common devices were implantable continuous (IC, 448 [40%]), followed by paracorporeal pulsatile (PP, 306 [28%]), paracorporeal continuous (PC, 293 [26%]), and percutaneous (58 [5%]). Patients with percutaneous device, infants, congenital heart disease, biventricular support, and Interagency Registry for Mechanically Assisted Circulatory Support profile 1 had worse overall survival at 6 months. Positive outcome was 83% at 6 months. Consistent with their cohort composition, device type positive outcomes at 6 months were IC, 92%; PP, 84%; and PC, 69%. Parametric hazard modeling for overall survival showed an early hazard for death with biventricular support, congenital heart disease (CHD), intubation before implantation, PC device, and renal impairment, whereas a constant hazard was associated with ascites. For patients <10 kg, parametric modeling showed an early hazard for CHD, intubation, and renal impairment. Modeling in CHD patients showed an early hazard for biventricular support, renal impairment, and use of PC/PP devices. Conclusions: This multivariable analysis of the complete Pedimacs database demonstrates that illness at VAD implantation, diagnosis, and strategy of support affect survival and differ by device type. We hope this is the first step in creating a predictive tool to help providers and families have informed expectations.
AB - Background: The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) provides detailed understanding on pediatric patients supported with ventricular assist devices (VADs). We sought to identify important variables affecting mortality in pediatric VADs. Methods: Patients aged <19 years, from 2012 to 2021, were included. Survival analyses were performed using Kaplan-Meier. Parametric hazard modeling was used to identify risk factors for death. Results: Of the 1109 patients, the most common devices were implantable continuous (IC, 448 [40%]), followed by paracorporeal pulsatile (PP, 306 [28%]), paracorporeal continuous (PC, 293 [26%]), and percutaneous (58 [5%]). Patients with percutaneous device, infants, congenital heart disease, biventricular support, and Interagency Registry for Mechanically Assisted Circulatory Support profile 1 had worse overall survival at 6 months. Positive outcome was 83% at 6 months. Consistent with their cohort composition, device type positive outcomes at 6 months were IC, 92%; PP, 84%; and PC, 69%. Parametric hazard modeling for overall survival showed an early hazard for death with biventricular support, congenital heart disease (CHD), intubation before implantation, PC device, and renal impairment, whereas a constant hazard was associated with ascites. For patients <10 kg, parametric modeling showed an early hazard for CHD, intubation, and renal impairment. Modeling in CHD patients showed an early hazard for biventricular support, renal impairment, and use of PC/PP devices. Conclusions: This multivariable analysis of the complete Pedimacs database demonstrates that illness at VAD implantation, diagnosis, and strategy of support affect survival and differ by device type. We hope this is the first step in creating a predictive tool to help providers and families have informed expectations.
UR - http://www.scopus.com/inward/record.url?scp=85170230259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85170230259&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2023.07.039
DO - 10.1016/j.athoracsur.2023.07.039
M3 - Article
C2 - 37573991
AN - SCOPUS:85170230259
SN - 0003-4975
VL - 116
SP - 972
EP - 979
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 5
ER -